These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 3876835
1. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency. Goday A, Simmonds HA, Morris GS, Fairbanks LD. Biochem Pharmacol; 1985 Oct 01; 34(19):3561-9. PubMed ID: 3876835 [Abstract] [Full Text] [Related]
2. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine. Goday A, Simmonds HA, Morris GS, Fairbanks LD. Clin Exp Immunol; 1984 Apr 01; 56(1):39-48. PubMed ID: 6424986 [Abstract] [Full Text] [Related]
3. B-lymphocytes, thymocytes and platelets accumulate high dATP levels in simulated ADA deficiency. Goday A, Simmonds HA, Fairbanks LD, Morris GS. Adv Exp Med Biol; 1986 Apr 01; 195 Pt A():515-20. PubMed ID: 3487922 [No Abstract] [Full Text] [Related]
4. dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: significance for the immune response? Simmonds HA, Goday A, Morris GS, Fairbanks LD, Levinsky RJ. Biosci Rep; 1984 Oct 01; 4(10):809-18. PubMed ID: 6335053 [Abstract] [Full Text] [Related]
5. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat. Barton RW. Cell Immunol; 1985 Oct 15; 95(2):297-310. PubMed ID: 3876160 [Abstract] [Full Text] [Related]
6. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells. Bagnara AS, Hershfield MS. Proc Natl Acad Sci U S A; 1982 Apr 15; 79(8):2673-7. PubMed ID: 6283540 [Abstract] [Full Text] [Related]
7. Metabolism of deoxynucleosides by lymphocytes in long-term culture deficient in different purine enzymes. Simmonds HA, Goday A, Morris GS, Brolsma MF. Biochem Pharmacol; 1984 Mar 01; 33(5):763-70. PubMed ID: 6424679 [Abstract] [Full Text] [Related]
8. Establishment and characterization of adenosine deaminase-deficient human T cell lines. Kohn DB, Mitsuya H, Ballow M, Selegue JE, Barankiewicz J, Cohen A, Gelfand E, Anderson WF, Blaese RM. J Immunol; 1989 Jun 01; 142(11):3971-7. PubMed ID: 2497184 [Abstract] [Full Text] [Related]
9. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency. Simmonds HA, Webster DR, Perrett D, Reiter S, Levinsky RJ. Biosci Rep; 1982 May 01; 2(5):303-14. PubMed ID: 6980023 [Abstract] [Full Text] [Related]
10. Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency. Fairbanks LD, Taddeo A, Duley JA, Simmonds HA. J Immunol; 1990 Jan 15; 144(2):485-91. PubMed ID: 2104895 [Abstract] [Full Text] [Related]
11. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase. Lee N, Russell N, Ganeshaguru K, Jackson BF, Piga A, Prentice HG, Foa R, Hoffbrand AV. Br J Haematol; 1984 Jan 15; 56(1):107-19. PubMed ID: 6231047 [Abstract] [Full Text] [Related]
12. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells. Webster AD, Ip H, Pereira S. Clin Exp Immunol; 1982 Dec 15; 50(3):587-95. PubMed ID: 6299634 [Abstract] [Full Text] [Related]
13. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes. Ratech H, Kim J, Asofsky R, Thorbecke GJ, Hirschhorn R. J Immunol; 1984 Jun 15; 132(6):3077-84. PubMed ID: 6202772 [Abstract] [Full Text] [Related]
14. Severe combined immunodeficiency in a child with a healthy adenosine deaminase deficient mother. Schmalstieg FC, Mills GC, Tsuda H, Goldman AS. Pediatr Res; 1983 Dec 15; 17(12):935-40. PubMed ID: 6606796 [Abstract] [Full Text] [Related]
15. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor. Ratech H, Thorbecke GJ, Hirschhorn R. Clin Immunol Immunopathol; 1981 Oct 15; 21(1):119-27. PubMed ID: 6268339 [No Abstract] [Full Text] [Related]
16. Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes. Gruber HE, Cohen AH, Firestein GS, Redelman D, Bluestein HG. Adv Exp Med Biol; 1986 Oct 15; 195 Pt A():503-7. PubMed ID: 3487921 [No Abstract] [Full Text] [Related]
17. Importance of platelet-free preparations for evaluating lymphocyte nucleotide levels in inherited or acquired immunodeficiency syndromes. Goday A, Simmonds HA, Webster DR, Levinsky RJ, Watson AR, Hoffbrand AV. Clin Sci (Lond); 1983 Dec 15; 65(6):635-43. PubMed ID: 6414755 [Abstract] [Full Text] [Related]
18. ATP depletion as a consequence of adenosine deaminase inhibition in man. Siaw MF, Mitchell BS, Koller CA, Coleman MS, Hutton JJ. Proc Natl Acad Sci U S A; 1980 Oct 15; 77(10):6157-61. PubMed ID: 6969403 [Abstract] [Full Text] [Related]
19. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients. Hirschhorn R, Roegner-Maniscalco V, Kuritsky L, Rosen FS. J Clin Invest; 1981 Dec 15; 68(6):1387-93. PubMed ID: 7033281 [Abstract] [Full Text] [Related]
20. Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation. Van De Wiele CJ, Vaughn JG, Blackburn MR, Ledent CA, Jacobson M, Jiang H, Thompson LF. J Clin Invest; 2002 Aug 15; 110(3):395-402. PubMed ID: 12163459 [Abstract] [Full Text] [Related] Page: [Next] [New Search]